An Open Single Centre Evaluation of the Reactivity of the T.R.U.E. Test Quaternium-15 Patch and a Real Use Exposure in Subjects Known to Be Allergic to Quaternium-15
The study is required by the FDA as part of a post-marketing commitment. The purpose of the study is to compare the reactivity of the TRUE Test quaternium-15 patch and a real use exposure.The subjects will wear the patch test for 48 hours and reading will be performed day 3 or 4. The use test will be applied from day 3 or 4 and untill reaction appears. Reactions from respectively TRUE Test and use test will be compared using the McNemar Change Test.
An open single centre evaluation of the reactivity of the T.R.U.E TestTM Quaternium-15 patch and a real use exposure in subjects known to be allergic to Quaternium-15.
Clinical Evaluation of Bacitracin. A Phase II Dose-Response Study
The purpose of this study is to establish a concentration of a bacitracin-patch for diagnosing allergic contact dermatitis.
100 项与 Mekos Laboratories AS 相关的临床结果
0 项与 Mekos Laboratories AS 相关的专利（医药）
100 项与 Mekos Laboratories AS 相关的药物交易
100 项与 Mekos Laboratories AS 相关的转化医学
